Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Utility of COVID-19 Screening in Cancer Patients.

Lee LYW., Hill T., Topping O., Tilby M., Baker M., Greig J., Isherwood L., Miller R., Petrenko Y., Desai R., Field A., Kennedy B., Khan S., Kountourou A., Ndlovu S., Starkey T., Storey F., Turner L., Vaughan-Williams W., Moyler S., Preston H., Latty B., Walker S., Henderson DR., Thompson J., Jones N., Ghafoor Q., Pascoe J., Williams S., Middleton G., UK Birmingham Chemotherapy Cancer COVID-19 Project .

More information

DOI

10.1016/j.ccell.2020.07.009

Type

Journal article

Publication Date

01/09/2020

Volume

38

Pages

306 - 307

Total pages

1

Addresses

Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cancer and Genomic Sciences, University of Birmingham, UK. Electronic address: l.lee.2@bham.ac.uk.

Keywords

UK Birmingham Chemotherapy Cancer COVID-19 Project, Humans, Pneumonia, Viral, Coronavirus Infections, Neoplasms, Prevalence, Pandemics, United Kingdom, Betacoronavirus, COVID-19, SARS-CoV-2